These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33871044)

  • 41. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
    Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
    Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of methadone, opium tincture and buprenorphine maintenance therapies on thyroid function in patients with OUD.
    Shakeri H; Hejrati R; Hojjat SK; Khalili MN; Farazmand T; Mollazadeh S
    J Addict Dis; 2020; 38(4):514-519. PubMed ID: 32749208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
    Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
    Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
    Mannelli P; Peindl KS; Lee T; Bhatia KS; Wu LT
    Curr Drug Abuse Rev; 2012 Mar; 5(1):52-63. PubMed ID: 22280332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Buprenorphine for managing opioid withdrawal.
    Gowing L; Ali R; White JM; Mbewe D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.
    Manhapra A; Quinones L; Rosenheck R
    Drug Alcohol Depend; 2016 Mar; 160():82-9. PubMed ID: 26804898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
    Ward HB; Barnett BS; Suzuki J
    Subst Abus; 2019; 40(2):140-145. PubMed ID: 30888254
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
    Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
    N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids.
    Nielsen S; Larance B; Lintzeris N
    JAMA; 2017 Mar; 317(9):967-968. PubMed ID: 28267837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.
    Chisolm MS; Fitzsimons H; Leoutsakos JM; Acquavita SP; Heil SH; Wilson-Murphy M; Tuten M; Kaltenbach K; Martin PR; Winklbaur B; Jansson LM; Jones HE
    Nicotine Tob Res; 2013 Jul; 15(7):1297-304. PubMed ID: 23288871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine.
    Sen S; Arulkumar S; Cornett EM; Gayle JA; Flower RR; Fox CJ; Kaye AD
    Curr Pain Headache Rep; 2016 Mar; 20(3):16. PubMed ID: 26879874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
    Hser YI; Evans E; Huang D; Weiss R; Saxon A; Carroll KM; Woody G; Liu D; Wakim P; Matthews AG; Hatch-Maillette M; Jelstrom E; Wiest K; McLaughlin P; Ling W
    Addiction; 2016 Apr; 111(4):695-705. PubMed ID: 26599131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
    Clark RE; Baxter JD; Aweh G; O'Connell E; Fisher WH; Barton BA
    J Subst Abuse Treat; 2015 Oct; 57():75-80. PubMed ID: 25997674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.